Therefore, we recommend that CRC patients with a family history or who fulfil the Amsterdam/Bethesda clinical diagnostic criteria or patients with suspected LS-related tumours undergo screening for MMR gene mutations by genetic testing [13]. The gene discussed is MRC1; the disease is colorectal carcinoma.